WallStSmart
ADXN

Addex Therapeutics Ltd

NASDAQ: ADXN · HEALTHCARE · BIOTECHNOLOGY

$7.00
+3.86% today

Updated 2026-04-29

Market cap
$8.62M
P/E ratio
P/S ratio
54.40x
EPS (TTM)
$-9.17
Dividend yield
52W range
$5 – $12
Volume
0.0M

Addex Therapeutics Ltd (ADXN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item2006200720082009201020112012201320142015201620172018201920202021202220232024
Operating cash flow$-19.56M$-33.00M$-17.79M$-39.38M$-31.34M$-26.55M$-29.45M$-15.78M$-1.80M$-2.63M$-2.69M$-2.13M$1.75M$-9.48M$-12.18M$-14.71M$-16.44M$-7.99M$-5.37M
Capital expenditures$357410.00$2.73M$5.61M$4.21M$453018.00$204314.00$330906.00$0.00$0.00$11197.00$11221.00$697.00$9054.00$28459.00$59414.00$31549.00$581.00$6842.00$1273.00
Depreciation
Stock-based comp$526780.00$599670.00$772940.00$580482.00$174475.00$275740.00$355909.00$197347.00$800188.00$2.30M$1.69M$1.18M$1.18M$3.68M$1.79M
Free cash flow$-19.92M$-35.73M$-23.40M$-43.59M$-31.79M$-26.75M$-29.78M$-15.78M$-1.80M$-2.64M$-2.71M$-2.14M$1.74M$-9.51M$-12.24M$-14.74M$-16.44M$-8.00M$-5.37M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$390189.00$307496.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$0.00$0.00